The patient was enrolled in (b)(6) clinical study with the patient identifier of (b)(6).It was reported that in-stent stenosis of right mid superficial femoral artery (sfa) occurred.Procedure summary: as part of (b)(6) clinical study, the patient underwent treatment with the eluvia stent on (b)(6) 2016.The target lesion was located in right leg mid sfa with 90% stenosis and was 120 mm long with a proximal reference vessel diameter of 6.00 mm and distal vessel diameter of 6.00 mm and was classified as tasc ii b lesion.Target lesion was treated with pre-dilatation and placement of a 6x150 mm,130 cm eluvia drug-eluting vascular stent system.Following post-dilatation, residual stenosis was 0 percent.280 days post index procedure, patient visited the hospital for 12 month follow up visit.Duplex ultra sound core lab finding noted in-stent stenosis category as 50-99% in the target lesion.On (b)(6) 2018, during the 24 months follow up, duplex ultrasound core lab finding noted a in-stent stenosis category as 50-99% in the target lesion.No further patient complications were reported.
|